Related Experiment Video
Updated: Aug 7, 2026

Detection of Signaling Effector-Complexes Downstream of BMP4 Using in situ PLA, a Proximity Ligation Assay
Published on: March 3, 2011
Physical and functional interactions between the prostate suppressor homeoprotein NKX3.1 and serum response factor
Jeong Ho Ju1, Jin-Soo Maeng, Micheas Zemedkun
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3800 Reservoir Road, NW, Washington, DC 20007, USA.
Abstract:
The NKX3.1 transcription factor is an NK family homeodomain protein and a tumor suppressor gene that is haploinsufficient and down-regulated in the early phases of prostate cancer. Like its cardiac homolog, NKX2.5, NKX3.1 acts synergistically with serum response factor (SRF) to activate expression from the smooth muscle gamma-actin (SMGA) gene promoter. Using NMR spectroscopy, three conserved motifs in a construct containing the N-terminal region and homeodomain of NKX3.1 were observed to interact with the MADS box domain of SRF. These motifs interacted both in the absence of DNA and when both proteins were bound to a SMGA promoter DNA sequence. No significant interaction was seen between the homeodomain and SRF MADS box. One of the SRF-interacting regions was the tinman (TN) or engrailed homology-1 motif (EH-1), residues 29-35 (FLIQDIL), which for other NK proteins is the site of interaction with the repressor protein Groucho. A second hydrophobic interacting region was designated the SRF-interacting (SI) motif and included residues 99-105 (LGSYLLD). A third interacting motif was the acidic region adjacent to the SI motif including residues 88-96 (ETLAETEPE). The acidic domain (AD) motif signals also showed strengthening upon the NKX3.1 homeodomain binding to DNA in the absence of SRF, consistent with the acidic region weakly interacting with the homeodomain in the unbound state. The importance of these linear motifs in the transcriptional interaction of NKX3.1 and SRF was demonstrated by targeted mutagenesis of an NKX3.1 expression vector in a SMGA reporter assay. The results implicate the NKX3.1 N-terminal region in regulation of transcriptional activity of this tumor suppressor.
Insights
The NKX3.1 tumor suppressor protein interacts with serum response factor (SRF) via its N-terminal region to regulate gene expression. These interactions are crucial for NKX3.1
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- NKX3.1 is a prostate cancer tumor suppressor gene.
- NKX3.1 regulates gene expression synergistically with SRF.
- NKX3.1's interaction with SRF is critical for its function.
Purpose of the Study:
- To investigate the molecular mechanisms of NKX3.1 and SRF interaction.
- To identify the specific regions of NKX3.1 involved in SRF binding.
- To understand how these interactions affect transcriptional regulation.
Main Methods:
- Nuclear Magnetic Resonance (NMR) spectroscopy to study protein-protein interactions.
- Site-directed mutagenesis to probe the function of identified motifs.
- Reporter gene assays to assess transcriptional activity.
Main Results:
- NMR revealed three conserved motifs in NKX3.1's N-terminal region interact with SRF's MADS box domain.
- These interactions occur both in the absence and presence of DNA.
- Mutagenesis studies confirmed the importance of these motifs (TN, SI, and acidic domain) in NKX3.1-SRF transcriptional regulation.
Conclusions:
- The N-terminal region of NKX3.1 plays a key role in its transcriptional regulation through interaction with SRF.
- Specific linear motifs within the N-terminal region are critical for this interaction.
- Understanding these interactions may provide insights into prostate cancer development and treatment.
Related Concept Videos
Regulation of Nuclear Protein Sorting
Co-activators and Co-repressors
RNA Polymerase II Accessory Proteins
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
